#licensingagreement — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #licensingagreement, aggregated by home.social.
-
#Spotify and #Universal Music Group announced a #licensingagreement enabling Spotify to launch a tool for creating AI-generated covers and remixes. The tool, powered by generative AI technology, will be a paid add-on for Spotify Premium users and will allow artists and songwriters to share in the generated revenue. https://variety.com/2026/digital/news/spotify-universal-music-licensing-agreements-fan-made-covers-1236755951/?eicker.news #tech #media #news
-
#Spotify and #Universal Music Group announced a #licensingagreement enabling Spotify to launch a tool for creating AI-generated covers and remixes. The tool, powered by generative AI technology, will be a paid add-on for Spotify Premium users and will allow artists and songwriters to share in the generated revenue. https://variety.com/2026/digital/news/spotify-universal-music-licensing-agreements-fan-made-covers-1236755951/?eicker.news #tech #media #news
-
Technology licensing is a big thing for us at #VTTFinland and leap towards a larger scale manufacturing. Today #CanaryMedical has made an licensing agreement with VTT on our proprietary MEMS sensor technology for use in their implantable cardiovascular products
#MEMS #PMUT #PressureSensor #CardiovascularHealth #TechnologyLicensing #LicensingAgreement
-
Technology licensing is a big thing for us at #VTTFinland and leap towards a larger scale manufacturing. Today #CanaryMedical has made an licensing agreement with VTT on our proprietary MEMS sensor technology for use in their implantable cardiovascular products
#MEMS #PMUT #PressureSensor #CardiovascularHealth #TechnologyLicensing #LicensingAgreement
-
https://www.alojapan.com/1225634/alumis-and-kaken-sign-agreement-in-japan-to-develop-esk-001/ Alumis and Kaken sign agreement in Japan to develop ESK-001 #ClinicalDevelopment #commercialisation #Japan #JapanNews #JapanTopics #kaken #LicensingAgreement #news Alumis and Kaken Pharmaceutical have entered a partnership and licensing agreement for the development, manufacture and commercialisation of the former’s ESK-001 for dermatological indications in Japan. The agreement includes options to extend the licence to gastrointestinal and rh…